News & Media

News

November 16, 2022

n-Lorem Update

October 18, 2022

Sustainable Funding From a Diverse Donor Base Supports n-Lorem Foundation and its Nano-rare Patients

September 29, 2022

n-Lorem Foundation Promotes Sarah Glass, Ph.D. to Chief Operating Officer

September 15, 2022

n-Lorem Foundation CEO, Stanley Crooke, M.D., Ph.D., Chosen as 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien

September 13, 2022

SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy

July 26, 2022

n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research 

June 20, 2022

n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients

June 14, 2022

n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients 

May 25, 2022

n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families 

May 3, 2022

n-Lorem Foundation and Columbia University Establish Silence ALS Initiative 

April 26, 2022

n-Lorem Foundation Welcomes Amy McCooe to its Board of Directors 

April 21, 2022

n-Lorem and The Wolverine Foundation Collaborate to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients 

March 21, 2022

The Conrad Prebys Foundation to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients

March 18, 2022

San Diego Biotech Nonprofit Providing Hope for Patients With Ultra-Rare Diseases – NBC 7 San Diego

March 16, 2022

La Jolla Labs and n-Lorem Foundation Partner to Discover Personalized ASO Medicines for Nano-rare Patients

March 9, 2022

Second Anniversary for n-Lorem Foundation Marks Extraordinary Progress Toward Treating Nano-Rare Patients

February 23, 2022

Parexel and n-Lorem Foundation Partner to Support Development of New Investigational Therapies for Nano-rare Patients

February 8, 2022

n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases

February 2, 2022

n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare Diseases

January 27, 2022

n-Lorem Foundation Receives $1 million Donation from Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients

January 18, 2022

n-Lorem Foundation Partners with Alnylam to Expand Technology Access to RNAi Therapeutics for Patients with Nano-rare Diseases

January 13, 2022

n-Lorem Foundation Announces New Publication in Trends in Molecular Medicine

January 6, 2022

n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases

January 4, 2022

John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council

December 14, 2021

n-Lorem Foundation Welcomes New Members, Jason Wood and Gene Yeo, to its Board of Directors

August 17, 2021

n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer

June 16, 2021

n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases

May 26, 2021

n-Lorem Foundation Welcomes Frank J. Sasinowski to its Board of Directors

May 3, 2021

n-Lorem Foundation Applauds FDA’s Important and Highly Constructive Guidance for Individualized ASO Treatments for Patients with Ultra-Rare Conditions

April 13, 2021

n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases

April 6, 2021

n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases

March 12, 2021

Introducing n-Lorem Foundation – Creating a better future for ultra-rare, one patient at a time

January 26, 2021

n-Lorem Foundation Celebrates One-Year Anniversary as First and Only Organization to Offer Free, Personalized Treatment to Ultra-Rare Disease Patients

December 10, 2020

n-Lorem Foundation Receives $500,000 Donation to Develop Individualized Treatments for Patients with Ultra-Rare Diseases

July 29, 2020

How you can help provide experimental ASO treatments to patients with ultra-ultra-rare diseases.

June 12, 2020

Stan Crooke introduced n-Lorem Foundation at BIO Digital (June 8-12, 2020)

April 14, 2020

n-Lorem Foundation receives $500,000 donation for providing experimental antisense medicines to treat patients with ultra-rare diseases

March 19, 2020

Korea Institute of Toxicology joins growing list of global partners supporting n-Lorem’s efforts to deliver treatments for patients with ultra-rare diseases

March 12, 2020

n-Lorem Foundation receives additional support for providing “n of 1” experimental antisense medicines to treat patients with ultra-rare diseases

January 8, 2020

n-Lorem Foundation established to charitably provide antisense medicines to treat patients with ultra-rare diseases


Media

  • Logos
  • n-Lorem Brochure
  • Dr. Crooke's Bio & Photo